Veracyte, Inc.VCYTNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +28.58% | +20.81% | +18.20% | +13.75% | +13.82% |
| Gross Profit Growth | +26.42% | +14.43% | +27.28% | +15.22% | +15.53% |
| EBITDA Growth | +0.00% | +0.00% | +236.74% | -48.56% | +6.28% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | -214.37% | +90.95% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | -117.09% | +26.28% |
| EPS Growth | +0.00% | +0.00% | +0.00% | -117.86% | +21.55% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | -117.86% | +26.37% |
| Weighted Average Shares Growth | +5.78% | +6.16% | +4.37% | +2.19% | +2.22% |
| Weighted Average Shares Diluted Growth | +7.77% | +9.30% | +7.08% | +3.55% | +1.56% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +111.44% | +57.69% | +0.00% | +13.63% | +49.37% |
| Free Cash Flow Growth | +143.83% | +56.13% | +0.00% | +20.57% | +51.38% |
| Receivables Growth | +24.20% | +15.22% | +15.25% | +1.01% | -2.01% |
| Inventory Growth | +28.18% | +34.86% | +32.33% | +29.92% | -0.18% |
| Asset Growth | +13.34% | +16.60% | +9.61% | +8.89% | +7.28% |
| Book Value per Share Growth | +5.47% | +6.10% | +2.35% | +5.51% | +4.62% |
| Debt Growth | +43.47% | +301.72% | +259.69% | +144.22% | +105.41% |
| R&D Expense Growth | +31.92% | +3.30% | +10.99% | -1.22% | -9.06% |
| SG&A Expenses Growth | +16.15% | +13.69% | +20.69% | +4.88% | +7.32% |